Mycophenolate mofetil is effective only for involved skin in the treatment for steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

Ann Hematol. 2017 Feb;96(2):319-321. doi: 10.1007/s00277-016-2854-0. Epub 2016 Oct 21.

Authors

Kenichiro Hattori¹, Noriko Doki², Shuhei Kurosawa¹, Yutaro Hino¹, Keita Yamamoto¹, Masahiro Sakaguchi¹, Kaito Harada¹, Shuntaro Ikegawa¹, Naoki Shingai¹, Yasushi Senoo¹, Aiko Igarashi¹, Yuho Najima¹, Takeshi Kobayashi¹, Kazuhiko Kakihana¹, Hisashi Sakamaki¹, Kazuteru Ohashi¹

Affiliations

¹ Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo, 113-8677, Japan.
² Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo, 113-8677, Japan. n-doki@cick.jp.

PMID: 27766393
DOI: 10.1007/s00277-016-2854-0

No abstract available

Publication types

Letter

MeSH terms

Acute Disease
Anti-Bacterial Agents / therapeutic use
Female
Graft vs Host Disease / diagnosis
Graft vs Host Disease / drug therapy*
Graft vs Host Disease / etiology
Hematopoietic Stem Cell Transplantation / adverse effects*
Humans
Male
Mycophenolic Acid / therapeutic use*
Skin Diseases, Infectious / diagnosis
Skin Diseases, Infectious / drug therapy*
Skin Diseases, Infectious / etiology
Steroids / therapeutic use*
Transplantation, Homologous / adverse effects
Treatment Outcome

Substances

Anti-Bacterial Agents
Steroids
Mycophenolic Acid